Biopharmaceutical companies are increasingly challenged to create a drug pricing strategy that both rewards value and innovation, and promotes affordability and access.
During this webinar, PwC’s Health Research Institute will review findings from a new global survey of industry executives, and provide analysis and commentary on key drug pricing issues, including:
- US policy and regulatory changes and implications for manufacturers
- Market access and pricing issues in global markets
- Contracting and reimbursement models
- Price transparency
- Patient affordability